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Abstract 
To investigate the changes of blood flow signal in residual cancer after 
ultrasound-guided radiofrequency ablation(RFA) treatment of rabbit liver cancer over 
time , and to analyze the correlation between changes in blood flow signal and 
changes in HIF-1α, VEGF, and MMP-9 in residual cancer tissue after RFA. One 
hundred and ten rabits were randomly selected ,VX2 tumor cells were implanted 
subcutaneously, tumor cells were implanted in liver. 90 rabits were divided into 2 
groups. Group 1(untreated controls). Group 2  was surgical resection group ,tumor 
size, blood flow signal, Microvessel density (MVD) in liver cancer were counted, 
Correlation of HIF-1α, VEGF, MMP-9 mRNA and protein expressions with blood 
flow signal in residual cancer were observed.liver tumor was 2.3 ± 0.32 cm, 
significant differences in the grade of blood flow signal were noted among different 
time points (days 0, 3, 7, and 14) (P < 0.05). Significant differences were also 
observed between the surgical resection and RFA groups at the same time points (P < 
0.05),The MVD in the RFA group was lower than that in the control group, but higher 
than that in the surgical resection group. The immunohistochemical scores for VEGF 
and MMP-9 in the RFA group were lower than those in the control group, but higher 
than those in the surgical resection group .The grade of ultrasound blood flow signal 
was positively correlated with the expression of two angiogenesis-related factors, 
VEGF and MMP-9, and the MVD in the control, RFA, and surgical resection groups. 
There is a higher risk of tumor recurrence with RFA than with surgical resection. 
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Introduction 
Primary liver cancer, especially hepatocellular carcinoma, is a prevalent disease 
with a world-wide incidence of one million new cases each year. However, surgery is 
indicated only in 10% to 30% of the cases. Clinical studies have found that 
ultrasound-guided radiofrequency ablation (RFA) can control liver cancer and relieve 
the symptoms to some extent. However, it is difficult to achieve overall inactivation 
with RFA for large-diameter tumors. Although simultaneous multi-point ablation is an 
option, the mechanisms of neovascularization, recurrence, and metastasis of residual 
tumor have not been fully understood. It has been reported that RFA can induce 
hypoxia and significantly increased angiogenesis in surrounding surviving tissue 
while destroying tumor tissue. 
Previous studies have focused on the relationship between microvessel density 
and matrix metalloproteinase-9 or the pathological changes after RFA over a short 
observation period (24 hours). No studies have continuously observed the changes of 
blood flow signal in liver cancer after RFA over a long period (2 weeks), and analyzed 
the correlation between such changes and the dynamic changes of HIF-1α, vascular 
endothelial growth factor (VEGF), and matrix metalloproteinases (MMP)-9 in liver 
cancer. 
To this end, this study was conducted to investigate the changes of blood flow 
signal in residual cancer after RFA treatment of rabbit liver cancer over time (0 hours 
to 2 weeks), and to analyze the correlation between changes in blood flow signal and 
changes in HIF-1α, VEGF, and MMP-9 in residual cancer tissue after RFA. The 
results lay a foundation for the study of medication targets for the treatment of local 
tumor recurrence after RFA. 
 
1. Methods 
1.1 Animal model 
One hundred and ten randomly selected New Zealand white rabbits of clean 
grade (6-7 months old, male or female, 2300 g) from the Animal Center of Inner 
Mongolia Medical University were used. VX2 tumor cells supplied by Peking Union 
Medical College were implanted subcutaneously in the outer thigh of 5 rabbits and 
passaged. After 14-28 days, tumors growing at the implant site were dissected layer 
by layer and reserved. Next, the tumors were cut into 1-mm3 pieces under sterile 
conditions and placed in 0.9% physiological saline. The tumor pieces were ground 
and suspended separately, stored in a refrigerator at -80°C for 24 hours, and then 
stored in liquid nitrogen. One hundred and five randomly selected rabbits were fixed 
on the operating table after anesthesia via ear vein. Their abdominal cavity was 
opened by conventional operation of the right rib arch to expose the liver. Next, the 
liver was obliquely punctured with ophthalmic surgical forceps, implanted with the 
passaged tumor cells, and stuffed with surgical gelatin sponge. Afterwards, the 
abdomen was closed layer by layer. Ultrasound examination of tumor growth was 
performed after 60 days of feeding. Rabbits that suffered from surgical death and 
infection were excluded according to experimental requirements. The experimental 
rabbits were observed for general condition. The diameter of the implanted tumors 
was measured using a real-time color Doppler ultrasound diagnostic system, 
Logiq-E8-Face, with a probe frequency of 3.0-5.0 MHz. Five of the rabbits were 
sacrificed and pathological sections of liver cancer were prepared to observe the 
pathological changes. 
 
1.2 Evaluation of angiogenesis and blood flow signal in residual cancer after RFA 
and surgical resection in rabbits with liver cancer 
A total of 90 randomly selected rabbits with liver cancer were divided into 3 
groups. Group 1 consisted of 10 untreated controls. Group 2 consisted of 40 rabbits 
treated with RFA with 10% residual tumor and subdivided into 4 groups (each of 10 
rabbits): 0 hours after treatment, 3 days after treatment, 7 days after treatment, and 14 
days after treatment. Group 3 consisted of 40 rabbits treated with surgical resection 
with 10% residual tumor and subdivided into 4 groups (each of 10 rabbits): 0 hours 
after treatment, 3 days after treatment, 7 days after treatment, and 14 days after 
treatment. For group 2, after insertion of the RFA electrode into the liver tumor area, 
eccentric ablation was performed for 4 minutes at a power of 5 to 50 W. The system 
was automatically shut down when the impedance reached 100%. 10% of the tumor 
was left in situ. Afterwards, the electrode was removed and the abdomen was closed. 
Anti-inflammatory treatment was given. Group 3 underwent conventional liver tumor 
resection with 10% residual tumor. Afterwards, the abdomen was closed and 
anti-inflammatory treatment was given. The dynamic changes of microangiogenesis 
in residual cancer were examined by contrast-enhanced ultrasound in the three groups 
of rabbits 0, 3, 7 and 14 days after treatment. The ultrasound was performed on each 
rabbit with all the same parameters (mechanical index, gain, and depth). Tumor size 
and blood flow signal were evaluated by ultrasound examination. The blood flow 
signal was classified into four grades: grade 0, no blood flow signal; grade 1, sporadic 
star-shaped blood flow signal; grade 2, continuous stripe-shaped blood flow signal, 
representing continuous blood flow activity; and grade 3, presence of large vessels 
with a fast blood flow rate. 
The contrast agent used was Sonovuc (Bracco, Italy) and administered at the 
manufacturer’s recommended dose. The radiofrequency system used was an RFA 
treatment system with a double electrode configuration and a power of 50-60 HZ 
from Covidien (US). 
 
1.3 Relationship between blood flow signal and angiogenesis in residual cancer 
after RFA and surgical resection in rabbits with liver cancer 
Rabbits in the control, RFA, and surgical resection groups were sacrificed at the 
selected time points for tumor tissue sampling. One part of the collected tissue was 
stained and counted for microvessel density (MVD) in liver cancer; and the others 
were preserved in liquid nitrogen and embedded in paraffin separately. 
Microvessels were counted according to the MVD staining method proposed by 
Wendy. Brownish yellow staining of the interstitial substance indicated positive cells. 
Cell masses near the positive staining were vessels. Vessels were counted under low 
magnification in three selected fields with a relatively dense distribution. The mean ± 
standard deviation was calculated. 
The expression of VEGF and MMP-9 in liver cancer was measured using the 
S-P method. Rabbit polyclonal antibodies were used for the staining of VEGF and 
MMP-9. The embedded tissue was sectioned, washed 3 times with PBS, blocked with 
hydrogen peroxide for 10-15 minutes, and antigen-retrieved by high pressure and high 
temperature. Afterwards, the sections were cooled, washed 3 times with PBS, blocked 
with serum, and incubated for 15 minutes at 26°C. Next, VEGF and MMP-9 primary 
antibodies were added, followed by incubation for 2 hours at 37°C, and then 
secondary antibodies were added, followed by incubation for 15 minutes at room 
temperature. After washing with PBS, the sections were incubated with SP solution 
for 15 minutes at room temperature, then washed 3 times with PBS. Next, the sections 
were developed with DAB solution, washed with running water, then stained with 
hematoxylin, and observed under microscope. Furthermore, the sections were 
incubated with rabbit polyclonal antibodies against VEGF and MMP-9 for 1 hour at 
room temperature. At 1-5 minutes after addition of substrate (Abeam, Cambridge, 
UK), the sections were counterstained with hematoxylin, dehydrated, and mounted 
with coverslips. The results of immunohistochemistry were determined according to 
the instructions of VEGF and MMP-9 assay kits used, which describe VEGF and 
MMP-9 as localized in the cytoplasm. Five high-power fields were randomly selected 
for each slide using the image analysis software to determine the average optical 
density and for statistical analysis. 
 
1.4 Correlation of HIF-1α, VEGF, MMP-9 mRNA and protein expressions with 
blood flow signal in residual cancer after RFA and surgical resection in rabbits 
with liver cancer 
First, 100 mg of liver cancer tissue samples from each rabbit were homogenized 
with 1 ml of Trizol reagent (Invitrogen, Carlsbad, CA, USA). Total mRNA was 
isolated using Trizol reagent. Next, the RNA was redissolved. The RNA pellet was 
dried. The RNA sample was partially dissolved, triturated 5 times in RNase-free 
water, incubated at 55-60°C for 10 minutes, redissolved with 100% formamide, and 
stored at -70°C. Real-time quantitative PCR (RT-qPCR) was used to quantify HIF-1α, 
VEGF, and MMP-9 mRNA levels. The SYBR PrimeScript RT-qPCR kit (TaKaRa, 
Tokyo, Japan) was used. β-actin was used as an internal control. Primers used were as 
follows: for HIF-1α, 5’-GTCGGACAGCCTCACCAAACAGAGC3’’ (sense) and 
5’-GTTAACTTGATCCAAAGCTCTGAG-3’ (antisense); for VEGF, 
5’-CCCTGATGAGATCGAGTACATCTT-3’’ (sense) and 
5’-ACCGCCTCGGCTrGTCAC-3’ (antisense); for MMP-9, 
5’-CGGCCACGAGGAACAAACT-3’’ (sense) and 
5’-CGGAGCACGGAGACGGGTAT3’ (antisense); and for β-actin, 
5’-TTCTACAATGAGCTGCGTGTG-3’ (sense) and 
5’-GGGGTGTTGAAGGTCAAA-3’ (antisense). 
All primers were synthesized by Beijing Bioengineering Technology Co., Ltd. 
(Shanghai, China). The expression levels of HIF-1α, VEGF, and MMP-9 were 
expressed as a fold increase from the control, β-actin, and calculated using the ∆∆Ct 
method. 
The protein levels of HIF-1α, VEGF, and MMP-9 of selected tissue samples 
were analyzed by Western blotting. Tumor samples were homogenized prior to 
protein isolation. The homogenized samples were collected and dissolved using a 
bacteriolytic agent (Pierce, Rockford, IL, USA). A protease inhibitor cocktail (Thermo 
Fisher Scientific, Waltham, MA, USA) was added according to the manufacturer's 
instructions. Protein samples were separated on a 12% polyacrylamide gel and 
transferred to a nitrocellulose membrane. HIF-1α, VEGF, MMP-9, and β-actin were 
quantified by electrochemiluminescence (Amersham, Uppsala, Sweden) using 
polyclonal antibodies against rabbit HIF-1α, VEGF, MMP-9, and β-actin, 
respectively, and then a peroxidase-conjugated secondary antibody (Sigma, St. Louis, 
MO, USA). 
 
2 Results 
2.1. Of the 105 experimental rabbits, 4 died due to surgical infection, surgical errors, 
or unknown reasons; and 101 survived after tumor implantation. However, 
hyperechoic tumor was not observed in the liver by ultrasound in 3 of the surviving 
rabbits. The reason for this might be surgical errors or inactivation of the implanted 
tumor tissue. The remaining 98 surviving liver tumor-bearing rabbits had a tumor size 
of 2.3 ± 0.32 cm (Fig.1). Ultrasound revealed an intact capsule, high echo of the 
tumor parenchyma, and mostly wide, but occasionally narrow, surrounding dark 
halos. The main reason for this was that the tumor pushed away the surrounding small 
vessels and became surrounded by them. There were no obvious changes in echo 
intensity in the posterior aspect of liver tumor nodules in most cases. Posterior 
enhancement was occasionally seen. Masses were observed in adjacent tissues in a 
few animals. 
2.2. Five liver tumor-bearing rabbits were randomly selected and sacrificed. There 
was no difference in morphology between the harvested histopathological sections of 
liver cancer. Cancerous changes in liver cells were observed in all specimens, 
exhibiting apparent pathomorphology of liver cancer, often accompanied by 
megakaryocytes and multinuclear tumor cells. The nuclei were of different size, shape 
and staining properties. The chromatin was mostly unevenly distributed coarse 
granules. The nuclear membrane was thick, the nucleus divided, the nuclear division 
asymmetric, and the cytoplasm mostly basophilic (Figure 2). 
2.3. Immediately after ablation, echoes from microbubbles, with an unclear boundary, 
were detected around the ablation zone. Grade 1 blood flow signals were detected, 
i.e., almost no blood flow could be detected. Three days after ablation, tumor 
boundary and size were similar to those before ablation. The boundary was unclear. 
The ablation zone was hyperechoic. Grade 1 blood flow signals were detected, 
representing almost no blood flow. The remaining 98 surviving liver tumor-bearing 
rabbits had a tumor size of 2.3 ± 0.32 cm. Ultrasound revealed an intact capsule in 
almost all animals, high echo of the tumor parenchyma, and mostly wide, but 
occasionally narrow, surrounding dark halos. The main reason for this was that the 
tumor pushed away the surrounding small vessels and became surrounded by them. 
There were no obvious changes in echoes in the posterior aspect of liver tumor 
nodules in most cases. Posterior enhancement was occasionally seen. Masses were 
observed in adjacent tissues in a few animals (Fig. 3). 
Ultrasound performed from 7 to 14 days revealed an increasingly clear boundary, 
high or mixed medium-high echoes in the ablation zone, and blood flow signals of 
grades 2 and 3. Before treatment, there was no significant difference in the grade of 
blood flow signal between the control (n = 10), RFA (n = 40), and surgical resection 
(n = 40) groups (P > 0.05). After treatment, significant differences in the grade of 
blood flow signal were noted in the surgical resection group between different time 
points (days 0, 3, 7, and 14) (P < 0.05). Significant differences were also observed 
between the surgical resection and RFA groups at the same time points (P < 0.05). The 
blood flow signal intensity in the RFA group was lower than that in the control group, 
but higher than that in the surgical resection group. 
Before RFA, as revealed by contrast-enhanced ultrasound, the contrast around 
the liver cancer rapidly increased for 5-8 seconds, and disappeared approximately 20 
seconds later. At 0 and 3 days after RFA, blood flow signals appeared around the 
tumor, and a defect was present in the liver cancer area 15 seconds after contrast 
injection; and no blood flow signal was observed within the tumor. Blood flow 
enhancement occurred in the previous blood flow defect area in 2 animals on day 7 
and in 4 animals on day 14. Similarly, at 0 and 3 days after surgical resection, blood 
flow signals appeared around the tumor, and a defect was present in the liver cancer 
area 15 seconds after contrast injection; and no blood flow signal was observed within 
the tumor. Blood flow enhancement occurred in the previous blood flow defect area in 
1 animal on day 7 and in 2 animals on day 14. Significant differences were observed 
between the surgical resection and RFA groups at the same time points (P < 0.05). 
A 
Pathological observation after RFA revealed that the tissue in the ablation zone 
was mostly necrotic, with dark blue pyknotic nuclei, fragmented chromatin, dissolved 
nuclear membrane, no visible nuclear boundary, and swelling and liquefaction of the 
intercellular substance. At 7 and 14 days after RFA, liquefaction occurred in the 
ablation zone, the necrosis was extended, and fibrosis occurred around the liquefied 
area. 
 
2.4 Intratumoral microvessel density in control, RFA (4 subgroups), and surgical 
resection (4 subgroups) groups 
The intratumoral microvessel density (MVD) was 32.3 ± 2.3 in the control 
group. In the RFA group, the MVD was 10.3 ± 3.5 on day 0, 11.4 ± 2.8 on day 3, 17.3 
± 3.1 on day 7, and 31.5 ± 2.2 on day 14. In the surgical resection group, the MVD 
was 9.8 ± 2.4 on day 0, 9.8 ± 3.4 on day 3, 10.4 ± 1.9 on day 7, and 18.6 ± 2.1 on day 
14. Analysis of variance indicated P < 0.05, representing significant differences 
between groups. Significant differences were also observed between the surgical 
resection and RFA groups at the same time points (P < 0.05). The MVD in the RFA 
group was lower than that in the control group, but higher than that in the surgical 
resection group. 
 
2.5 Comparison of VEGF and MMP-9 expression between control, RFA (4 
subgroups), and surgical resection (4 subgroups) groups 
VEGF and MMP-9 expression in the control, RFA (4 subgroups), and surgical 
resection (4 subgroups) groups is shown in Table 2. Analysis of variance gave F = 
2973.896, P < 0.05 for VEGF expression, and F = 2275.421, P < 0.05 for MMP-9 
expression, both representing significant differences between groups. Significant 
differences were also observed between the surgical resection and RFA groups at the 
same time points (P < 0.05). The immunohistochemical scores for VEGF (Fig. 4) and 
MMP-9 (Fig. 5) in the RFA group were lower than those in the control group, but 
higher than those in the surgical resection group. 
 
2.6 Correlation of blood flow signal with VEGF and MMP-9 expression and 
MVD 
In the control group, the blood flow signal was positively correlated with the 
VEGF and MMP-9 expression and the MVD, with correlation coefficients of 0.521, 
0.768, and 0.814, respectively (all P < 0.05). The blood flow signal was positively 
correlated with the VEGF and MMP-9 expression and the MVD in both the RFA and 
surgical resection groups at all time points; in other words, the higher the blood 
supply grade, the higher the VEGF and MMP-9 expression and MVD. At later time 
points (days 7 and 14), both the VEGF and MMP-9 expression and the MVD were 
higher with RFA than with surgical resection. 
 
3. Discussion 
RFA is a minimally invasive, non-surgical technique in which a needle- or 
catheter-type electrode is inserted into tumor to produce heat (100-110°C) with a 460 
kHz radiofrequency current to kill tumor cells. Ultrasound-guided RFA has been 
shown to control liver cancer and relieve the symptoms to some extent in clinical 
research [3]. Ultrasound contrast agents used in recent years combined with 
high-resolution ultrasound can effectively monitor the properties and development of 
residual cancer after liver cancer ablation or surgical resection, providing an important 
basis for timely follow-up [4-6]. 
High-resolution ultrasonography was performed after ablation in this study. 
Immediately after ablation, echoes from microbubbles, with an unclear boundary, 
were detected around the ablation zone. Grade 1 blood flow signals were detected, 
representing almost no blood flow. Three days after ablation, tumor boundary and size 
were similar to those before ablation. The boundary was unclear. The ablation zone 
was hyperechoic. Grade 1 blood flow signals were detected, representing almost no 
blood flow. Ultrasound performed from 7 to 14 days revealed an increasingly clear 
boundary, high or mixed medium-high echoes in the ablation zone, and blood flow 
signals of grades 2 and 3. From the above results, it is clear that the liver tissue of the 
untreated control group had relatively high blood flow rates and metabolic activity. In 
the RFA group, necrosis occurred in the liver cancer tissue due to damage caused by 
radiofrequency hyperthermia at early time points after RFA. However, at later time 
points, the liver cancer tissue that was not damaged by radiofrequency hyperthermia 
continued to proliferate and undergo malignant change, leading to recurrence of liver 
cancer. In the surgical resection group, the blood flow in cancer decreased initially, 
but increased over time, similar to that observed with RFA. However, the blood flow 
rate was lower with surgical resection than with RFA at the same time points. It 
indicates that surgical resection can effectively reduce cancer recurrence compared 
with RFA.  
MVD is a relatively accurate indicator for determining local microangiogenesis. 
It is commonly used for local detection of tumors to determine the nature and 
recurrence of tumors [4, 5]. 
VEGF is also known as vascular permeability factor. It can be divided by 
structure and function into VEGF-A, -B, -C, -D, -E and -F.  It is a vital factor during 
vessel growth and development, promoting the growth and division of vascular 
endothelial cells [21]. VEGF can induce endothelial cell proliferation and cause 
increased permeability, leading to vascular edema and inflammation. The main role of 
VEGF is to regulate vascular permeability and promote the formation of fiber 
networks by vascular endothelial cells. In vitro, it can also promote proliferation, 
differentiation, migration, and adhesion of vascular endothelial cells, as well as matrix 
degradation, and activate bone marrow-derived endothelial progenitor cells. Liver 
cancer is a highly vascularized tumor. The hepatic artery provides the main source of 
blood supply to tumor cells. Liver cancer cells and tumor infiltrating inflammatory 
cells secrete VEGF, bFCF, PDGF, and some factors that promote neovascularization 
and vessel maturation. Clinical studies [6,7] suggest that VEGF can predict the 
prognosis of liver cancer; VEGF expression in patients with liver cancer was 
negatively correlated with their overall survival; and blocking tumor angiogenesis 
may therefore be a potential target for treatment of liver cancer. 
Metalloproteinases participate in histogenesis and organ development, and are 
closely related to tumorigenesis, cardiovascular diseases and central nervous diseases, 
mainly by affecting the extracellular matrix [8]. MMP-9 belongs to the second major 
category of MMPs, gelatinase. It is the enzyme with the largest molecular weight in 
the MMP family. It consists of three α-helices and five ß-sheets, containing two zinc 
ions and five calcium ions. In its structure, small molecule compounds, which are 
tightly bound to zinc ions, can be seen at the active center. MMP-9 is generally 
detected by zymography. The main steps of zymography are as follows: 1) separate 
the sample by SDS-polyacrylamide gel electrophoresis, 2) restore the activity of 
MMP-9 in the divalent metal ion buffer, 3) stain the gel after electrophoretic 
separation with Coomassie blue, 4) destain the gel, and 5) observe the bands in a blue 
background. The intensity of the bands reflects the activity of MMP-9. Therefore, 
measurement of MMP-9 is important for reflecting the level of angiogenesis. 
In this study, the blood flow signal was positively correlated with the VEGF 
and MMP-9 expression and the MVD in both the RFA and surgical resection groups; 
that is to say, the higher the blood flow signal grade, the higher the VEGF and 
MMP-9 expression and MVD. At later time points (days 7 and 14), both the VEGF 
and MMP-9 expression and the MVD were higher with RFA than with surgical 
resection. The results of this study demonstrate that the ultrasound blood flow signal 
is associated with the expression of two angiogenesis-related factors, VEGF and 
MMP-9, and the MVD in the control, RFA, and surgical resection groups.  This is 
consistent with the observations regarding blood flow signals and contrast-enhanced 
ultrasound findings described in section 2. It indicates that there is a higher risk of 
tumor recurrence with RFA than with surgical resection. The possibility of tumor 
recurrence after RFA can be assessed by measurement of VEGF and MMP-9 in 
clinical practice. 
 
4 Conclusions 
4.1. RFA can partially destroy tumors. However, the blood flow signal intensity was 
higher with RFA than with surgical resection at later time points after treatment. 
4.2. The grade of ultrasound blood flow signal was positively correlated with the 
expression of two angiogenesis-related factors, VEGF and MMP-9, and the 
MVD in the control, RFA, and surgical resection groups. 
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Figure legend 
 
Figure 1. Removed tumor implant from hind limb 
 Figure 2. HE staining of rabbit liver cancer tissue (SP × 200) 
 Figure 3. Ultrasound of rabbit liver cancer before and after RFA. A. Before RFA. B. 
After RFA. 
 
 Figure 4. VEGF protein expression in liver cancer (SP × 400). A and B: 
VEGF-positive cells; C: VEGF-negative cells. 
 Figure 5. MMP-9 protein expression in liver cancer (SP × 400). A and B: 
MMP-9-positive cells; C: MMP-9-negative cells. 
 
 
 
 
 
 
 
 
A 
Table 1. Vascular grade in three groups before and after RFA 
Group  Number Grade 
0 
Grade 
1 
Grade 
2 
Grade 
3 
       
Control Before RFA 10 2 3 5 0 
 After RFA  2 3 2 3 
RFA group Before RFA 40 8 14 5  
 0 days after RFA 10 7 2 1 0 
 3 days after RFA 10 5 3 2 0 
 7 days after RFA 10 4 3 2 1 
 14 days after RFA 10 3 4 2 1 
Surgical 
resection group 
Before resection 40 9 13 6 0 
 0 days after resection 10 8 1 1 0 
 3 days after resection 10 7 2 1 0 
 7 days after resection 10 6 4 0 0 
 14 days after resection 10 6 4 0 0 
 
 
Table 2. VEGF and MMP-9 expression in each group 
Group VEGF MMP9 
Control group 67.3±2.46 63.5±2.45 
RFA group   
Day 0 15.3±0.44 23.6±0.70 
Day 3 16.7±0.33 26.5±0.45 
Day 7 34.9±1.61 37.3±0.93 
Day 14 57.6±0.53 61.5±0.70 
Surgical resection group   
Day 0 16.8±0.72 22.7±0.69 
Day 3 15.2±0.75 23.6±0.48 
Day 7 26.6±0.66 28.6±0.65 
Day 14 35.2±0.72 39.6±0.96 
 
